BrainStorm Cell Names Revital Geffen-Aricha VP Of Research & Development

(RTTNews) - BrainStorm Cell Therapeutics Inc. (BCLI), a developer of adult stem cell technologies for neurodegenerative diseases, said it has appointed Dr. Revital Geffen-Aricha, as Vice President of Research and Development.

Dr. Geffen-Aricha will be based in Israel and report to Chaim Lebovits, President and Chief Executive Officer. She will be responsible for all research and development activities for BrainStorm.

Dr. Geffen-Aricha joined BrainStorm from the Weizmann Institute of Science, where she served as the Chief Resident of the department of Immunology since 2006.